CMX001
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for CMX001, covering 2016-06-07 to 2021-07-16. Get the full timeline:
Most recent: Clinical Trial Update: Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients [Phase 2]